Latest filing published 23 Apr 2026 for Day One Biopharmaceuticals, Inc.. Read the official filing
All filings by Charles N. York II on record concern Day One Biopharmaceuticals, Inc. Over a trading history stretching from 1 July 2022 to 23 April 2026, the count stands at 28 filings.
Every open-market trade on record is a sale: 12 sales worth €2.5M. Besides market trades, the filings include 15 option exercises.
The newest entry dates from 23 April 2026: a transaction, in Day One Biopharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations